Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Possible Mechanisms and Strategies for Immune Therapy Resistance in Gastric Cancer

Version 1 : Received: 18 September 2024 / Approved: 19 September 2024 / Online: 19 September 2024 (11:49:59 CEST)
Version 2 : Received: 7 October 2024 / Approved: 8 October 2024 / Online: 8 October 2024 (13:44:17 CEST)

How to cite: Yuyu, X.; Huiling, S. Possible Mechanisms and Strategies for Immune Therapy Resistance in Gastric Cancer. Preprints 2024, 2024091478. https://doi.org/10.20944/preprints202409.1478.v1 Yuyu, X.; Huiling, S. Possible Mechanisms and Strategies for Immune Therapy Resistance in Gastric Cancer. Preprints 2024, 2024091478. https://doi.org/10.20944/preprints202409.1478.v1

Abstract

Gastric cancer has become one of the most common cancers in the world.Immunotherapy, especially immune point inhibitors targeting programmed cell death 1 or its ligand PD-L1, has been successfully applied in the clinical treatment of GC. However, only a small number of cancer patients experience persistent clinical responses during immunotherapy. In this review, we discussed the current status of immunotherapy for colorectal cancer, elucidated the mechanisms mediating immunotherapy resistance, predicted biomarkers for immunotherapy resistance, and strategies for improving immunotherapy efficacy.

Keywords

gastric cancer; immunotherapy; Immune resistance; biomarker

Subject

Medicine and Pharmacology, Oncology and Oncogenics

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.